FMI opines the covid-19 saliva sampling test potential market was valued at USD 3.70 billion in 2025. Sales are expected to reach USD 3.84 billion in 2026 and USD 5.64 billion by 2036. Travel Stations is poised to lead by Venue Type with N/A% share in 2026 and Fluorescence-labeled Antigen/Antibodies Testing is estimated to command by Testing Technology in 2026.